TUSC1 and neoplasm: Also, the novel lncRNA MIR497HG considered new tumor suppressors and prognostic biomarkers in glioma and significantly inhibited glioma cell proliferation ability and cell cycle progression via targeting CCNE1 and the miR-588/TUSC1 axis (Ji et al., 2021).